method
quantit
determin
protein
composit
adenovirusvector
base
vaccin
develop
final
method
use
rpuplc
uv
absorb
detect
column
mm
wateracetonitril
acn
gradient
contain
trifluoroacet
acid
tfa
ionpair
agent
chromatograph
resolut
variou
adenoviru
protein
optim
studi
effect
tfa
concentr
column
temperatur
appli
full
factori
design
experi
reproduc
baselin
separ
relev
adenoviru
protein
could
achiev
within
min
run
time
sampl
contain
adenoviru
particl
could
directli
inject
uplc
system
without
sampl
pretreat
virus
reproduc
dissoci
protein
uplc
system
upon
contact
mobil
phase
contain
acn
new
rpuplc
method
success
valid
protein
profil
rel
quantif
protein
vaccin
product
base
adenoviru
vector
type
intermedi
precis
rel
peak
area
protein
rsd
except
peak
assign
protein
v
rsd
method
prove
stabil
indic
respect
thermal
oxid
stress
adenovirusvector
base
vaccin
success
implement
character
adenovirusbas
product
adenovirus
nonenvelop
icosahedralshap
virus
nm
consist
protein
capsid
contain
doubl
strand
dna
genom
adenovirus
promis
vector
intracellular
deliveri
dna
advac
technolog
combin
technolog
allow
product
adenoviru
vector
viral
dna
modifi
encod
antigen
interest
exampl
case
ebola
vaccin
adenoviru
vector
modifi
encod
certain
glycoprotein
ebola
viru
upon
vaccin
glycoprotein
express
host
cell
present
immun
system
therebi
expectedli
elicit
protect
immun
respons
ebola
viru
adenoviru
proteom
compos
differ
protein
vari
stoichiometri
adenoviru
protein
identifi
number
order
decreas
molecular
weight
observ
sdspage
viru
capsid
consist
trimer
protein
ii
hexon
copi
protein
iii
penton
base
fiber
protein
iv
extend
outward
penton
base
consid
essenti
bind
adenoviru
cell
surfac
four
minor
protein
iiia
vi
viii
ix
locat
inner
side
capsid
thought
act
cement
protein
core
particl
contain
six
differ
protein
v
vii
x
termin
protein
tp
adenoviru
proteas
avp
viral
protein
ident
heterogen
content
adenoviru
particl
determin
ident
particl
interact
cell
possibl
stabil
incorrect
protein
express
viru
particl
correctli
assembl
could
lead
adenovirus
decreas
biolog
activ
therefor
vaccin
decreas
potenc
addit
degrad
modifi
protein
adenoviru
vector
liu
et
al
particl
could
also
result
decreas
biolog
activ
advers
effect
upon
vaccin
administr
challeng
develop
suitabl
analyt
method
analysi
adenoviru
protein
due
great
dynam
rang
need
measur
protein
subunit
concentr
simultan
due
larg
variabl
protein
size
charg
molecular
mass
adenoviru
protein
rang
kda
copi
number
per
viru
particl
tp
protein
ii
monom
addit
layer
complex
ad
need
disassembl
adenoviru
stabl
analyz
protein
analysi
typic
extens
sampl
treatment
requir
denatur
virus
protein
remov
matrix
compon
eg
surfact
sampl
concentr
sampl
intact
protein
biopharmaceut
product
commonli
analyz
spectrometri
electrophoresi
liquid
chromatographi
mass
spectrometri
specif
viral
protein
typic
analyz
sdspage
capillari
gel
electrophoresi
cge
rphplc
sdspage
extens
use
adenoviru
protein
analysi
key
protein
adenoviru
separ
sdspage
ms
use
ingel
trypsin
digest
band
assign
method
allow
accur
quantif
adenoviru
protein
due
poor
separ
gel
addit
protein
modif
exampl
detect
ms
could
introduc
harsh
sdspage
ms
pretreat
condit
capillari
gel
electrophoresi
appli
analysi
recombin
gb
virusc
protein
analysi
four
major
influenza
viru
protein
character
protein
western
eastern
venezuelan
equin
enceph
weve
viru
like
particl
vlp
downsid
capillari
gel
electrophoresi
method
limit
molecular
weight
rang
method
low
effici
protein
size
lower
kda
larger
kda
result
insuffici
resolut
anoth
drawback
extens
sampl
treatment
requir
denatur
reduc
alkyl
viru
sampl
analysi
cge
liquid
chromatographybas
method
analysi
intact
protein
viru
virusbas
vaccin
report
literatur
although
rplc
alreadi
establish
techniqu
protein
analysi
recent
technolog
develop
especi
improv
stationari
phase
ie
particl
size
pore
size
allow
even
better
reproduc
separ
intact
protein
anoth
technic
improv
introduct
lowbind
materi
lc
equip
decreas
artifact
adsorpt
injector
tube
etc
rphplc
use
analysi
nucleocapsid
protein
nprotein
sever
acut
respiratori
syndrom
sar
coronaviru
separ
revers
phase
column
particl
size
pore
size
acnwat
trifluoroacet
acid
tfa
mobil
phase
prior
analysi
sampl
dialyz
lyophil
concentr
method
achiev
baselin
resolut
analyt
interest
interf
peak
sampl
matrix
nprotein
could
identifi
fraction
collect
malditof
analysi
rphplc
also
use
quantif
influenza
hemagglutinin
protein
ha
influenza
viru
ha
cleav
trypsin
hydrophil
hydrophob
fragment
rphplc
fragment
wellresolv
sampl
compon
quantit
method
extern
calibr
report
literatur
sampl
prepar
method
labori
timeconsum
major
protein
influenza
viru
np
could
detect
rphplc
uv
absorb
detect
base
lehmberg
et
al
liu
et
al
use
qualiti
control
protein
profil
adenoviru
vaccin
product
see
fig
exampl
chromatogram
disadvantag
rphplc
method
inadequ
resolut
certain
protein
eg
protein
ii
ix
insuffici
repeat
retent
time
peak
area
therefor
reliabl
quantif
protein
rphplc
possibl
anoth
drawback
rphplc
method
long
run
time
min
limit
throughput
sampl
per
sequenc
includ
control
blank
sampl
instabl
observ
sampl
storag
h
auto
sampler
paper
describ
develop
valid
rpuplc
method
protein
profil
adenoviru
serotyp
adenoviru
vectorbas
vaccin
product
method
two
purpos
confirm
ident
test
sampl
detect
protein
modif
degrad
product
adenoviru
vector
ident
purpos
protein
profil
test
sampl
compar
profil
refer
sampl
base
rel
retent
time
rel
peak
area
calcul
rel
peak
area
peak
chromatogram
identifi
new
peak
chromatogram
method
also
allow
detect
degrad
product
sampl
addit
requir
method
develop
chromatograph
run
time
less
min
baselin
separ
relev
adenoviru
protein
allow
quantif
increas
method
robust
acetonitril
uplcm
grade
pn
biosolv
valkenswaard
netherland
acetonitril
gradient
grade
sn
trifluoroacet
acid
pn
cytochromec
pn
sigmaaldrich
zwijndrecht
netherland
methanol
pn
milliq
water
merck
millipor
amsterdamzuidoost
netherland
formul
buffer
refer
materi
transgen
b
c
refer
materi
transgen
b
process
sampl
janssen
vaccin
leiden
netherland
water
acquiti
hclass
uplc
system
equip
quaternari
solvent
manag
autosampl
pda
detector
water
corp
usa
use
data
process
perform
empow
softwar
variou
set
test
method
develop
set
final
valid
method
follow
analyt
column
acquiti
uplc
protein
beh
column
mm
new
analyt
column
precondit
inject
l
mgml
cytochromec
follow
inject
l
milliq
water
prevent
unwant
protein
adsorpt
stationari
phase
solvent
vv
acetonitril
acn
milliq
water
solvent
b
acn
solvent
c
wv
tfa
acn
b
c
linear
elut
gradient
form
acn
acn
contain
wv
tfa
min
flow
rate
mlmin
inject
volum
l
column
temperatur
c
auto
sampler
temperatur
c
detect
uvabsorb
monitor
nm
analys
system
flush
vv
acn
milliq
needl
wash
vv
acn
milliq
pump
seal
wash
vv
methanol
milliq
prepar
run
intend
peak
assign
sampl
select
advac
vaccin
first
concentr
ml
eppendorf
lobind
microcentrifug
tube
protein
hamburg
germani
centrifug
eppendorf
microcentrifug
g
min
c
remov
supernat
concentr
sampl
analyz
rpuplc
method
water
acquiti
hclass
uplc
system
method
describ
section
fraction
collect
everi
min
eppendorf
twintec
pcr
plate
lobind
use
fraction
collector
triversa
nanom
advion
ithaca
ny
usa
fraction
dri
vacuum
centrifug
without
heat
h
pellet
resuspend
l
acn
l
trypsin
solut
gml
mm
ammonium
bicarbon
ad
sampl
incub
overnight
c
tryptic
digest
dri
vacuum
centrifug
resuspend
l
acn
formic
acid
trypsin
digest
analyz
lcm
e
water
acquiti
hclass
uplc
system
coupl
water
synapt
mass
spectromet
water
corp
usa
analyt
column
acquiti
uplc
protein
beh
column
mm
solvent
formic
acid
milliq
water
solvent
b
formic
acid
acn
elut
linear
gradient
b
b
min
flow
rate
mlmin
inject
volum
l
column
temperatur
c
autosampl
temperatur
c
ms
e
condit
collis
energi
v
ramp
lockmass
solut
leucin
enkephalin
ngml
acnmilliq
water
formic
acid
lockmass
flow
lmin
capillari
voltag
kv
sampl
cone
temperatur
c
sourc
temperatur
c
desolv
ga
lh
cone
ga
flow
rate
lh
employ
resolut
mode
scan
per
sampl
adenoviru
vector
type
base
vaccin
first
dilut
viru
particl
vp
ml
formul
buffer
follow
stress
condit
appli
thermal
stress
incub
c
min
oxid
stress
addit
vv
hydrogen
peroxid
incub
h
stress
sampl
analyz
capillari
zone
electrophoresi
cze
accord
van
tricht
et
al
potenc
assay
accord
et
al
rpuplc
describ
section
compar
differ
techniqu
recoveri
stress
sampl
nonstress
sampl
use
ie
total
peak
area
recoveri
rpuplc
potenc
recoveri
potenc
assay
viru
particl
concentr
recoveri
cze
specif
demonstr
develop
protein
msbase
peak
assign
demonstr
absenc
viral
protein
formul
buffer
method
repeat
accuraci
intermedi
precis
linear
determin
concentr
level
rang
vpml
replic
concentr
level
repeat
differ
day
two
oper
two
analyt
column
two
lc
instrument
method
repeat
requir
rsd
rel
peak
area
rsd
rel
retent
time
intermedi
precis
determin
base
method
repeat
linear
data
three
differ
day
limit
rsd
rel
peak
area
rsd
rel
retent
time
linear
requir
r
sum
residu
less
accuraci
requir
recoveri
rel
peak
area
limit
quantif
loq
determin
lowest
concentr
level
met
requir
accuraci
precis
robust
deriv
result
method
develop
obtain
design
experi
origin
rphplc
method
base
lehmberg
et
al
liu
et
al
adenoviru
protein
separ
column
mm
wateracn
gradient
three
segment
differ
slope
acn
contain
tfa
min
see
fig
adenoviru
sampl
directli
inject
uplc
system
without
sampl
pretreat
eg
denatur
reduct
dilut
virus
dissoci
protein
upon
come
contact
wateracn
mobil
phase
uplc
system
dissoci
virus
protein
prior
uplc
analysi
result
irreproduc
chromatogram
data
shown
method
transfer
uplc
xbridg
beh
column
mm
linear
gradient
three
slope
replac
singleslop
linear
gradient
improv
elut
reproduc
flow
rate
increas
critic
method
paramet
rpuplc
method
studi
screen
design
experi
assess
impact
method
run
time
resolut
adenoviru
protein
follow
condit
evalu
gradient
start
composit
solvent
b
gradient
end
composit
solvent
b
gradient
run
time
min
tfa
concentr
column
temperatur
c
jmp
statist
softwar
use
fit
model
base
standard
least
squar
use
main
effect
paramet
respons
chosen
studi
effect
test
paramet
best
resolut
maximum
number
protein
peak
shortest
run
time
paretoanalysi
standard
paramet
estim
conclud
tfa
concentr
column
temperatur
strongest
impact
respons
peak
approxim
min
protein
v
vii
viii
min
protein
iiia
ix
influenc
column
temperatur
tfa
concentr
fig
c
gj
best
resolut
differ
peak
obtain
highest
concentr
tfa
column
temperatur
c
fig
gradient
start
end
composit
gradient
time
critic
regard
resolut
elut
order
provid
gradient
start
composit
acn
assur
complet
dissoci
viru
particl
end
composit
acn
allow
elut
adenoviru
protein
base
feasibl
experi
gradient
start
composit
fix
b
end
composit
b
gradient
time
min
set
result
shortest
run
time
best
resolut
possibl
initi
solvent
b
prepar
tfa
howev
allow
rang
tfa
concentr
caus
daytoday
variabl
ie
shift
retent
time
indic
tfa
concentr
critic
method
paramet
need
tightli
control
fig
show
tfa
signific
effect
separ
even
slight
chang
tfa
method
robust
respect
paramet
examin
specif
design
experi
see
section
addit
increas
reproduc
mobil
phase
composit
gradient
mobil
phase
prepar
method
chang
follow
solvent
acn
water
solvent
b
acn
solvent
c
tfa
acn
uplcsystem
use
mix
three
solvent
reproduc
obtain
constant
concentr
tfa
mobil
phase
throughout
gradient
effect
tfa
concentr
mobil
phase
column
temperatur
studi
fullfactori
design
factor
level
factor
level
aim
reduc
total
run
time
analyt
method
improv
separ
critic
peak
pair
vviii
viii
vii
viivi
vi
vi
iiix
ixiiia
select
factor
tfa
concentr
column
temperatur
c
studi
execut
analyz
sampl
respons
consid
evalu
effect
retent
time
protein
ii
use
indic
method
run
time
separ
critic
peak
pair
see
protein
peak
width
significantli
chang
test
condit
differ
retent
time
critic
peak
pair
use
instead
resolut
indic
separ
protein
retent
differ
min
higher
correspond
baselin
separ
data
process
jmp
statist
softwar
base
factor
main
effect
interact
effect
adenoviru
type
fig
type
fig
b
critic
peak
pair
baselin
separ
min
use
tfa
column
temperatur
c
contour
plot
fig
summar
result
design
experi
peak
pair
iiix
vviii
baselin
separ
test
condit
retent
time
differ
min
fig
column
temperatur
c
separ
peak
pair
vi
vi
compromis
resolut
tfa
concentr
fig
remain
accept
baselin
resolut
peak
pair
column
temperatur
c
higher
result
insuffici
separ
three
five
peak
pair
tfa
robust
method
small
chang
tfa
concentr
studi
assess
reproduc
retent
time
peak
area
sampl
analyz
four
dif
ferent
tfa
condit
three
independ
analysi
per
test
tfa
concentr
tfa
mobil
phase
fig
retent
time
peak
area
tfa
compar
retent
time
peak
area
default
condit
tfa
critic
peak
pair
alway
baselin
separ
peak
area
retent
time
tfa
deviat
compar
optim
system
employ
tfa
percentag
mobil
phase
base
result
conclud
method
robust
within
concentr
rang
tfa
provid
mobil
phase
prepar
describ
section
peak
assign
respect
adenoviru
protein
separ
lc
ms
analysi
due
presenc
tfa
mobil
phase
possibl
attain
accur
mass
data
form
intact
adenoviru
protein
onlin
coupl
ms
therefor
fraction
collect
rpuplc
chromatogram
digest
trypsin
subsequ
analyz
rphplcm
e
order
identifi
protein
peptid
map
peak
observ
fig
could
assign
protein
ii
iii
iiia
v
vi
vii
viii
ix
x
multipl
fragment
cleavag
protein
vi
viii
identifi
mark
vi
vi
vi
viii
viii
inde
matur
adenoviru
complet
infecti
viru
particl
involv
proteolyt
cleavag
capsid
core
protein
adenoviru
proteinas
avp
result
peak
assign
indic
sampl
contain
matur
adenoviru
particl
fiber
protein
iv
also
identifi
retent
time
min
peak
height
close
limit
detect
rpuplcuv
method
termin
protein
could
identifi
rpuplcuv
chromatogram
probabl
low
copi
number
n
viru
comparison
copi
number
protein
ii
protein
assign
last
two
peak
rpuplc
chromatogram
fig
associ
matur
viru
particl
report
present
immatur
viru
particl
preliminari
data
show
peak
area
ratio
kiii
viii
iii
viii
iii
measur
rel
concentr
immatur
adenoviru
particl
line
observ
takahashi
et
al
vellekamp
et
al
summari
method
repeat
intermedi
precis
previou
method
rphplc
rpuplc
precis
given
overal
precis
rsd
includ
concentr
level
test
protein
optim
rpuplcuv
method
intend
protein
profil
vectorbas
vaccin
product
protein
profil
test
sampl
compar
profil
refer
sampl
base
rel
retent
time
rel
peak
area
first
purpos
comparison
confirm
ident
adenoviru
vector
type
base
match
rel
retent
time
detect
adenoviru
protein
test
sampl
versu
refer
ie
protein
fingerprint
second
purpos
detect
potenti
protein
modif
degrad
product
vaccin
product
monitor
rel
peak
area
peak
chromatogram
includ
previous
unidentifi
peak
valid
method
two
purpos
specif
precis
accuraci
linear
loq
assess
specif
method
adenoviru
protein
demonstr
ms
method
develop
see
paragraph
demonstr
absenc
peak
assign
viral
protein
chromatogram
formul
buffer
blank
precis
evalu
method
repeat
intermedi
precis
rel
peak
area
rel
retent
time
method
repeat
rel
retent
time
protein
rsd
method
repeat
rel
peak
area
rsd
signific
improv
compar
current
rphplc
method
method
repeat
rsd
tabl
intermedi
precis
rel
retent
time
rsd
rsd
rel
peak
area
tabl
met
accept
criterion
method
valid
rsd
except
rel
peak
area
protein
v
rsd
higher
obtain
protein
meet
accept
criterion
method
valid
linear
demonstr
sampl
dilut
formul
buffer
within
rang
vpml
determin
coeffici
peak
area
base
five
concentr
level
three
replic
level
accuraci
absolut
peak
area
could
determin
spike
recoveri
due
unavail
pure
adenoviru
protein
standard
therefor
accuraci
determin
percentag
recoveri
measur
rel
peak
area
expect
rel
peak
area
concentr
level
base
dilut
linear
highest
concentr
level
recoveri
rel
peak
area
adenoviru
protein
loq
method
lowest
concentr
level
within
linear
rang
accept
precis
accuraci
vpml
rpuplcuv
method
valid
quantif
protein
v
sinc
peak
area
repeat
higher
criterion
protein
iv
vi
viii
k
k
could
quantifi
peak
area
limit
detect
summari
method
valid
quantif
rel
peak
area
adenoviru
protein
ii
iii
iiia
vi
vi
vii
viii
viii
ix
x
detect
adenoviru
protein
iv
v
vi
viii
k
k
adenoviru
type
type
vectorbas
vaccin
product
assess
rpuplcuv
method
pick
chang
protein
composit
may
occur
product
storag
sampl
stress
differ
condit
character
sever
physicochem
biochem
method
stress
condit
compris
oxid
peroxid
temperatur
stress
c
min
stress
sampl
nonstress
control
sampl
analyz
rpuplcuv
chromatogram
stress
sampl
compar
control
sampl
base
rel
retent
time
rel
peak
area
stress
sampl
also
analyz
capillari
zone
electrophoresi
potenc
assay
determin
concentr
viru
particl
infect
respect
thermal
stress
c
min
result
overal
rpuplc
peak
area
decreas
approxim
thermal
stress
min
result
decreas
overal
peak
area
consequ
protein
close
limit
quantif
rel
peak
area
protein
howev
temperaturestress
sampl
compar
nonstress
sampl
cze
analysi
temperaturestress
sampl
show
decreas
viru
particl
concentr
min
min
line
peak
area
decreas
rpuplc
chromatogram
fig
suggest
temperatur
stress
result
loss
viru
particl
rather
specif
degrad
adenoviru
protein
sampl
infect
decreas
stress
time
min
respect
oxid
stress
result
loss
almost
adenoviru
protein
approx
overal
chromatogram
peak
area
decreas
number
new
peak
observ
chromatogram
tent
assign
oxid
adenoviru
protein
rel
peak
area
chang
oxid
stress
due
new
peak
viru
particl
concentr
measur
cze
decreas
infect
decreas
indic
almost
adenoviru
particl
degrad
oxid
sampl
rpuplc
method
sensit
temperatur
stress
oxid
stress
valid
method
implement
analysi
adenovirusbas
product
exampl
provid
fig
describ
fig
show
chromatogram
process
intermedi
sampl
store
month
c
normal
storag
condit
final
product
c
peak
area
decreas
factor
compar
refer
sampl
fig
moreov
degrad
product
observ
shoulder
peak
protein
ii
min
peak
identifi
ms
intact
protein
ii
oxid
deamid
modif
fig
show
partial
purifi
sampl
downstream
process
addit
peak
detect
rpuplc
chromatogram
min
dad
spectra
peak
show
typic
protein
spectrum
characterist
fraction
contain
peak
collect
analyz
gcm
lcm
peak
min
min
assign
di
tertbutylphenol
respect
could
leachabl
dispos
contain
bag
use
process
trace
c
fig
anoth
partial
purifi
process
intermedi
sampl
high
concentr
host
cell
protein
impur
dad
spectra
addit
peak
show
typic
proteinspectra
howev
rel
peak
area
adenoviru
protein
unchang
compar
refer
sampl
case
fraction
addit
peak
collect
analyz
lcm
unknown
peak
min
assign
host
cell
protein
present
high
concentr
could
therefor
detect
rpuplc
method
rpuplc
method
develop
valid
protein
profil
adenoviru
type
type
protein
compar
current
use
rphplc
method
method
run
time
decreas
min
min
allow
analysi
sampl
per
day
instead
protein
profil
chang
observ
upon
oxid
stress
adenoviru
sampl
indic
method
use
monitor
stabil
adenoviru
vectorbas
vaccin
analysi
process
intermedi
sampl
show
abil
rpuplc
method
detect
possibl
quantifi
protein
degrad
leachabl
host
cell
protein
impur
futur
method
develop
direct
toward
enhanc
sensit
rpuplc
method
abl
accur
quantifi
protein
iv
fiber
protein
exampl
altern
detect
mode
fluoresc
explor
new
rpuplc
method
use
addit
analyt
toolbox
analysi
adenovirusbas
product
allow
rapid
accur
quantif
adenoviru
protein
profil
protein
degrad
product
